Previous 10 | Next 10 |
2023-05-22 12:55:14 ET Gainers: Microbot Medical ( MBOT ) +132% . Greenhill & Co ( GHL ) +117% . Hepion Pharmaceuticals ( HEPA ) +64% . Akebia Therapeutics ( AKBA ) +39% . VectivBio Holding ( VECT ) +36% . Atea Phar...
2023-05-15 17:20:48 ET Absci press release ( NASDAQ: ABSI ): Q1 GAAP EPS of -$0.26. Revenue of $1.3M (+62.5% Y/Y). For further details see: Absci GAAP EPS of -$0.26, revenue of $1.3M
Commenced work plan preparations and expect to initiate program work during second quarter leveraging Absci's generative AI drug creation platform for Phase II candidate Achieved rapid advancements of generative AI drug creation platform, continually building on prior breakthroughs ...
VANCOUVER, Wash. and OXFORD, UK, May 11, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and the University of Oxford’s Kennedy Institute of Rheumatology , a biomedical research center developing new therapies for chronic in...
VANCOUVER, Wash. and NEW YORK, April 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 22 nd Annual Needham Virtual Healthcare Conference. Absci management is scheduled ...
2023-04-04 11:58:02 ET Absci Corp ( NASDAQ: ABSI ) has partnered with M2GEN to develop new cancer medicines more rapidly than is currently done. Absci's ( ABSI ) artificial intelligence drug creation platform will use M2GEN's clinical and molecular data set, OR...
VANCOUVER, Wash. and TAMPA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and M2GEN , an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomics data to accelerate discovery resea...
2023-04-01 10:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...
2023-03-31 15:00:41 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...
2023-03-31 00:33:34 ET Absci press release ( NASDAQ: ABSI ): Q4 GAAP EPS of -$0.21 beats by $0.04 . Revenue of $1.56M (+7.6% Y/Y) misses by $2.54M . For further details see: Absci GAAP EPS of -$0.21 beats by $0.04, revenue of $1.56M misses by $2.54M
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Wash. and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the second quarter after market close on Wednesday,...
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...
VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3 rd Annual Life Sciences AI Summit on June 26-27 in New York, ...